A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis.
Epistemonikos ID: 138daea8aa2ac0f1c03969dc992e1623da8ed607
First added on: May 22, 2024